ArticlePloS one2024
Exploring the link between dietary thiamine and type 2 diabetes mellitus risk in US adults aged 45 years and older: Insights from a cross-sectional investigation.
Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The correlation between dietary thiamine intake and the incidence of type 2 diabetes mellitus (T2DM) remains a subject of controversy within the academic community. While numerous studies have attempted to elucidate this relationship, conclusive evidence remains elusive. A survey of U.S. adults aged 45 years and older examined the supposed association between dietary thiamine intake and the risk of developing T2DM with the aim of clarifying the potential link. In this cross-sectional investigation, we evaluated dietary thiamine intake data sourced from the National Health and Nutrition Examination Survey (NHANES) from 2007 to 2020. Using weighted multivariate logistic regression analysis, we assessed the potential risk of T2DM associated with varying levels of thiamine intake. The observation of nonlinear relationships was accomplished by fitting smoothed curves. This study ultimately included 15,231 participants aged 45 years and older. Dietary thiamine intake (after log transformation) was inversely related to T2DM after accounting for potential confounders (OR = 0.86, 95% CI: 0.78, 0.95). An increase in dietary thiamine intake by one unit is associated with a 14% reduction in the risk of T2DM. Furthermore, our analysis revealed that the associations between dietary thiamine intake and T2DM risk, such as age, gender, race, smoking status, alcohol use, hypertension, body mass index (BMI), and cardiovascular disease (CVD), remained consistent across multiple stratified subgroups (p values >0.05). According to this study, dietary thiamine intake may be associated with the incidence of T2DM among US residents aged 45 years and older. Appropriate increases in dietary thiamine intake are expected to offer substantial preventive potential for T2DM and significant clinical implications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.